| MicroRNAs (miRNAs) involve in members of biological process, including early embryonic development, cell proliferation, differentiation and apoptosis, tumorigenesis and lipid metabolism. The related functional studies have confirmed that miRNA-101a (miR-101a) involved in the regulation of cell proliferation and differentiation, however, its role in skeletal muscle development was unclear.In this study, we amplified the sequence of precursor miR-101a adding its flanking sequence, analyzed the expression profile of miR-101a in different tissues and its role in the regulation of SMSC proliferation and differention. EZH2, the inhibitor of muscular cell differentiation, had the target site of miR-101a through dual luciferase report system. We further analyzed the change to the mRNA expression of miR-101a after overexpression or inhibition of miR-101a. We revealed that the molecular mechanism of miR-101a in the regulation of skeletal muscle development whereby the inhibition of its target gene EZH2. The main results are as follows:1. The precursor miR-101a adding its flanking sequence was 448 bp amplified from whole genome DNA of goat, the mature miR-101a in different species was highly conserved, the precursor miR-101a of goat conformed to the characteristics of microRNA structure on the online RNAfold software analysis, the relative expression of miR-101a in muscle tissues of triceps, longissimus dorsi, semimembranosus, and psoas major was higher than in other tissues, such as heart, liver, spleen, lung and kidney, by RT-qPCR and semi-quantitative PCR.2. During SMSC cultured in vitro, the mRNA expression of Pax7 was enriched in the proliferation stage, accompanied by the decreased expression during SMSC differentiation; MyoD had high expression in proliferation and the early stage of differentiation; MyoG had the highest expression level in the differentiation and fusion of 3 d; MyHC was increasedly expressed in the differentiation process. We detected the expression of miR-101a in 0 dã€1 dã€3 dã€5dã€7 d of SMSC differentiation by RT-qPCR, the results showed that the expression of miR-101a was up-regulated during SMSC differentiation.3. We induced SMSC overexpressed or inhibited of miR-101a to differentiation for 48 h before detection the mRNA expression changes of muscular cell marker gene Pax7ã€MyoDã€MyoGã€MyHC. The results indicated that expression of MyoG and MyHC was significantly up-regulated (P<0.01), but accompanied with the significant down-regulation of Pax7 and MyoD (P<0.01) after overexpressing the miR-101a; on the contrary, expression of MyoG (P<0.01) and MyHC (P<0.05) was significantly down-regulated but accompanied with the significant up-regulation of Pax7 (P<0.01) and MyoD (P<0.05) after inhibiting the miR-101a. Taken together, miR-101a can promote satellite cell differentiation.4. We applied the CCK-8 detection reagent to analyze the effect of miR-101a on the proliferation of SMSC, the results reported that miR-101a had no significant influence (p>0.05) on satellite cell proliferation compared with the NC.5. We used TargetScan, miRanda and PicTar application software to predict the target gene for miR-101a, then selected the candidate target gene EZH2 (inhibitor of muscular cell differentiation). The recombinant vector of PGL3-Control-EZH2 was successfully constructed. We cotransfected the miR-101a or inhibitor and recombinant vector plasmids into SMSC, then we verified the target sites of EZH2 3’-UTR region which complement to the seed region of miR-101 a through detection of luciferase activity.6. We detected the mRNA expression of target gene EZH2 during the SMSC differentiation of 0 d,1 d,3 d,5 d and 7 d adding after overexpressing or inhibiting of miR-101a, the results showed that it was down-regulated during SMSC differentiation however, the mRNA expression of EZH2 had no significant change (p>0.05) compared with the NC by RT-qPCR analysis after overexpression or inhibition of miR-101a. These results prompted that miR-101 a may promote skeletal muscle differentiation by inhibition the protein level of target gene EZH2. |